๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer

โœ Scribed by M. Ghosn, A. Saroufim, J. Kattan, G. Chahine, F. Nasr, F. Farhat


Book ID
118821591
Publisher
Springer US
Year
2012
Tongue
English
Weight
278 KB
Volume
29
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Gemcitabine in locally advanced and/or m
โœ Hans von der Maase ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 90 KB

Gemcitabine is a promising new drug in patients with locally advanced and/or metastatic transitional cell carcinoma of the urothelium. The drug has been tested as a single-agent in one phase I study and four phase II studies. Gemcitabine was administered on days 1, 8 and 15 every 28 days with a dose